tiprankstipranks
Trending News
More News >
Moleculin Biotech (MBRX)
NASDAQ:MBRX
US Market

Moleculin Biotech (MBRX) Financial Statements

Compare
1,916 Followers

Moleculin Biotech Financial Overview

Moleculin Biotech's market cap is currently $12.26M. The company's EPS TTM is $-17.015; its P/E ratio is -0.07; Moleculin Biotech is scheduled to report earnings on November 17, 2025, and the estimated EPS forecast is $-6.11. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -26.64M$ -29.63M$ -30.64M$ -22.97M$ -19.74M
EBITDA$ -26.52M$ -29.50M$ -30.51M$ -22.80M$ -19.54M
Net Income$ -21.76M$ -29.77M$ -29.02M$ -15.89M$ -17.36M
Balance Sheet
Cash & Short-Term Investments$ 4.28M$ 23.55M$ 43.15M$ 70.90M$ 15.17M
Total Assets$ 16.93M$ 38.22M$ 57.42M$ 84.09M$ 29.16M
Total Debt$ 478.00K$ 574.00K$ 451.00K$ 159.00K$ 277.00K
Net Debt$ -3.80M$ -22.98M$ -42.69M$ -70.74M$ -14.90M
Total Liabilities$ 10.95M$ 12.14M$ 5.23M$ 5.10M$ 11.27M
Stockholders' Equity$ 5.98M$ 26.07M$ 52.19M$ 78.99M$ 17.89M
Cash Flow
Free Cash Flow$ -23.88M$ -24.23M$ -27.71M$ -18.97M$ -18.15M
Operating Cash Flow$ -23.86M$ -24.10M$ -27.64M$ -18.95M$ -17.77M
Investing Cash Flow$ -13.00K$ -124.00K$ -67.00K$ -19.00K$ -374.00K
Financing Cash Flow$ 4.63M$ 4.65M$ -23.00K$ 74.72M$ 22.55M
Currency in USD

Moleculin Biotech Earnings and Revenue History

Moleculin Biotech Debt to Assets

Moleculin Biotech Cash Flow

Moleculin Biotech Forecast EPS vs Actual EPS